Cargando…

Changes in Splicing Machinery Components Influence, Precede, and Early Predict the Development of Type 2 Diabetes: From the CORDIOPREV Study

BACKGROUND: Type-2 diabetes mellitus (T2DM) is a major health problem with increasing incidence, which severely impacts cardiovascular disease. Because T2DM is associated with altered gene expression and aberrant splicing, we hypothesized that dysregulations in splicing machinery could precede, cont...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gahete, Manuel D., del Rio-Moreno, Mercedes, Camargo, Antonio, Alcala-Diaz, Juan F., Alors-Perez, Emilia, Delgado-Lista, Javier, Reyes, Oscar, Ventura, Sebastian, Perez-Martínez, Pablo, Castaño, Justo P., Lopez-Miranda, José, Luque, Raul M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Research paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286259/ https://www.ncbi.nlm.nih.gov/pubmed/30446432 http://dx.doi.org/10.1016/j.ebiom.2018.10.056

Ejemplares similares

Dietary Intervention Modulates the Expression of Splicing Machinery in Cardiovascular Patients at High Risk of Type 2 Diabetes Development: From the CORDIOPREV Study
por: del Río-Moreno, Mercedes, et al.
Publicado: (2020)

An altered microbiota pattern precedes Type 2 diabetes mellitus development: From the CORDIOPREV study
por: Vals-Delgado, Cristina, et al.
Publicado: (2021)

Dysregulation of the splicing machinery is directly associated to aggressiveness of prostate cancer
por: Jiménez-Vacas, Juan M., et al.
Publicado: (2020)

A plasma circulating miRNAs profile predicts type 2 diabetes mellitus and prediabetes: from the CORDIOPREV study
por: Jiménez-Lucena, Rosa, et al.
Publicado: (2018)

A set of miRNAs predicts T2DM remission in patients with coronary heart disease: from the CORDIOPREV study
por: Rangel-Zuñiga, Oriol Alberto, et al.
Publicado: (2020)

A microbiota‐based predictive model for type 2 diabetes remission induced by dietary intervention: From the CORDIOPREV study
por: Vals‐Delgado, Cristina, et al.
Publicado: (2021)

Circulating miRNAs as Predictive Biomarkers of Type 2 Diabetes Mellitus Development in Coronary Heart Disease Patients from the CORDIOPREV Study
por: Jiménez-Lucena, Rosa, et al.
Publicado: (2018)

Evolution of Metabolic Phenotypes of Obesity in Coronary Patients after 5 Years of Dietary Intervention: From the CORDIOPREV Study
por: Martin-Piedra, Laura, et al.
Publicado: (2021)

A plasma fatty acid profile associated to type 2 diabetes development: from the CORDIOPREV study
por: Villasanta-Gonzalez, Alejandro, et al.
Publicado: (2021)

Influence of Obesity and Metabolic Disease on Carotid Atherosclerosis in Patients with Coronary Artery Disease (CordioPrev Study)
por: Talavera-Garcia, Eva, et al.
Publicado: (2016)

Metabolomics analysis of type 2 diabetes remission identifies 12 metabolites with predictive capacity: a CORDIOPREV clinical trial study
por: Mora-Ortiz, Marina, et al.
Publicado: (2022)

Hepatic insulin resistance both in prediabetic and diabetic patients determines postprandial lipoprotein metabolism: from the CORDIOPREV study
por: Leon-Acuña, A., et al.
Publicado: (2016)

Altered splicing machinery in lung carcinoids unveils NOVA1, PRPF8 and SRSF10 as novel candidates to understand tumor biology and expand biomarker discovery
por: Blázquez-Encinas, Ricardo, et al.
Publicado: (2023)

Splicing machinery dysregulation drives glioblastoma development/aggressiveness: oncogenic role of SRSF3
por: Fuentes-Fayos, Antonio C, et al.
Publicado: (2020)

Mediterranean diet and endothelial function in patients with coronary heart disease: An analysis of the CORDIOPREV randomized controlled trial
por: Yubero-Serrano, Elena M., et al.
Publicado: (2020)

Hypertriglyceridemia Influences the Degree of Postprandial Lipemic Response in Patients with Metabolic Syndrome and Coronary Artery Disease: From the Cordioprev Study
por: Alcala-Diaz, Juan F., et al.
Publicado: (2014)

Correction: Influence of Obesity and Metabolic Disease on Carotid Atherosclerosis in Patients with Coronary Artery Disease (CordioPrev Study)
por: Talavera-Garcia, Eva, et al.
Publicado: (2016)

Spliceosomal profiling identifies EIF4A3 as a novel oncogene in hepatocellular carcinoma acting through the modulation of FGFR4 splicing
por: López‐Cánovas, Juan L., et al.
Publicado: (2022)

Diet and SIRT1 Genotype Interact to Modulate Aging-Related Processes in Patients with Coronary Heart Disease: From the CORDIOPREV Study
por: Hidalgo-Moyano, Cristina, et al.
Publicado: (2022)

Plasma lipidic fingerprint associated with type 2 diabetes in patients with coronary heart disease: CORDIOPREV study
por: Villasanta-Gonzalez, Alejandro, et al.
Publicado: (2023)

Splicing alterations in pancreatic ductal adenocarcinoma: a new molecular landscape with translational potential
por: Alors-Pérez, Emilia, et al.
Publicado: (2023)

Age-dependent effect of metabolic phenotypes on carotid atherosclerotic disease in coronary heart disease patients (CORDIOPREV study)
por: Gutierrez-Mariscal, Francisco M., et al.
Publicado: (2020)

Long-term effect of a dietary intervention with two-healthy dietary approaches on food intake and nutrient density in coronary patients: results from the CORDIOPREV trial
por: Cano-Ibáñez, Naomi, et al.
Publicado: (2022)

HDL cholesterol efflux normalised to apoA-I is associated with future development of type 2 diabetes: from the CORDIOPREV trial
por: Blanco-Rojo, Ruth, et al.
Publicado: (2017)

THU080 Splicing Machinery Dysregulation As A Source Of Novel Diagnostic, Prognostic And Therapeutic Targets In Craniopharyngiomas
por: Fuentes-Fayos, Antonio C, et al.
Publicado: (2023)

Correction to: Long‑term effect of a dietary intervention with two‑healthy dietary approaches on food intake and nutrient density in coronary patients: results from the CORDIOPREV trial
por: Cano-Ibáñez, Naomi, et al.
Publicado: (2022)

Splicing Machinery is Dysregulated in Pituitary Neuroendocrine Tumors and is Associated with Aggressiveness Features
por: Vázquez-Borrego, Mari C., et al.
Publicado: (2019)

Splicing machinery is impaired in rheumatoid arthritis, associated with disease activity and modulated by anti-TNF therapy
por: Ibáñez-Costa, Alejandro, et al.
Publicado: (2022)

Ghrelin-O-Acyltransferase (GOAT) Enzyme as a Novel Potential Biomarker in Gastroenteropancreatic Neuroendocrine Tumors
por: Herrera-Martínez, Aura D., et al.
Publicado: (2018)

Quality and Quantity of Protein Intake Influence Incidence of Type 2 Diabetes Mellitus in Coronary Heart Disease Patients: From the CORDIOPREV Study
por: de la Cruz-Ares, Silvia, et al.
Publicado: (2021)

Dysregulated splicing factor SF3B1 unveils a dual therapeutic vulnerability to target pancreatic cancer cells and cancer stem cells with an anti-splicing drug
por: Alors-Perez, Emilia, et al.
Publicado: (2021)

The uprise of RNA biology in neuroendocrine neoplasms: altered splicing and RNA species unveil translational opportunities
por: Blázquez-Encinas, Ricardo, et al.
Publicado: (2022)

Changes in quantity plant-based protein intake on type 2 diabetes remission in coronary heart disease patients: from the CORDIOPREV study
por: Gutierrez-Mariscal, Francisco M., et al.
Publicado: (2023)

Molecular and Clinical Implications of Somatostatin Receptor Profile and Somatostatin Analogues Treatment in Oral Cavity Squamous Cell Carcinoma
por: Sanjuan-Sanjuan, Alba, et al.
Publicado: (2021)

Association between cholesterol efflux capacity and peripheral artery disease in coronary heart disease patients with and without type 2 diabetes: from the CORDIOPREV study
por: Yubero-Serrano, Elena M., et al.
Publicado: (2021)

Correction to: Association between cholesterol efflux capacity and peripheral artery disease in coronary heart disease patients with and without type 2 diabetes: from the CORDIOPREV study
por: Yubero-Serrano, Elena M., et al.
Publicado: (2021)

Serum Magnesium is associated with Carotid Atherosclerosis in patients with high cardiovascular risk (CORDIOPREV Study)
por: Rodríguez-Ortiz, M. Encarnación, et al.
Publicado: (2019)

Somatostatin Receptor Splicing Variant sst5TMD4 Overexpression in Glioblastoma Is Associated with Poor Survival, Increased Aggressiveness Features, and Somatostatin Analogs Resistance
por: Fuentes-Fayos, Antonio C., et al.
Publicado: (2022)

SUN-LB056 The Pharmacological Blockade of the Splicing Factor SF3B1 Exerts Antitumor Actions in Different Endocrine-Related Cancers
por: Gahete, Manuel, et al.
Publicado: (2019)

PRPF8 increases the aggressiveness of hepatocellular carcinoma by regulating FAK/AKT pathway via fibronectin 1 splicing
por: López-Cánovas, Juan L., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4qq65u37c8s967fesn649cd3nm